We next investigated whether some of the 28 candidate biomarkers (the 18 increased and 7 decreased proteins listed in the 3 versus 1 comparison, plus CAPG, FABP4, and LAMB2) common to the rat and human MM (Figure 2D) exhibited additional abundance changes during the carcinogenesis process. This evidence concerns the gene FABP4 and Miyoshi myopathy.